Breast tumour thymidine kinase levels and disease recurrence.
Thymidine kinase (TK) exists in two forms, TK1 and TK2. TK levels and oestrogen receptor status (OR) were measured in tumours from 86 patients with operable breast cancer and the patients were monitored for recurrence over 24 months. During the monitored period, 13 patients showed recurrence. These patients also exhibited higher total TK levels per mg tumour (P < 0.01) and higher TK1 levels (P < 0.001) than those who did not show recurrence. TK1 levels relative to TK2 were significantly higher (P < 0.05) in OR-negative tumours (n = 29) than in OR-positive tumours (n = 57). OR-negative (n = 9) and OR-positive (n = 4) patients who recurred had significantly higher TK1 levels relative to TK2 than did those who not recur (n = 20 and n = 53, respectively). These preliminary results indicate that breast tumour TK levels may have value in determining prognosis.
O'Neill
K L
KL
Department of Biological and Biomedical Sciences, University of Ulster, Coleraine, Northern Ireland.
McKelvey
V J
VJ
Hoper
M
M
Monteverde
H
H
Odling-Smee
G W
GW
Logan
H
H
Abram
W P
WP
McKenna
P G
PG
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry / Q000201:enzymology* / Q000601:surgery; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000201:enzymology*; D011960:Receptors, Estrogen / Q000032:analysis; D013937:Thymidine Kinase / Q000032:analysis*
D014408:Biomarkers, Tumor; D011960:Receptors, Estrogen; D013937:Thymidine Kinase